Farmaceutica REMEDIA Statistics

Total Valuation

Farmaceutica REMEDIA has a market cap or net worth of RON 69.05 million. The enterprise value is 23.66 million.

Market Cap	69.05M
Enterprise Value	23.66M

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	Sep 11, 2024

Share Statistics

Farmaceutica REMEDIA has 92.32 million shares outstanding. The number of shares has increased by 7.37% in one year.

Shares Outstanding	92.32M
Shares Change (YoY)	+7.37%
Shares Change (QoQ)	+30.09%
Owned by Insiders (%)	84.24%
Owned by Institutions (%)	0.29%
Float	14.55M

Valuation Ratios

The trailing PE ratio is 21.95.

PE Ratio	21.95
Forward PE	n/a
PS Ratio	0.12
PB Ratio	1.44
P/FCF Ratio	3.89
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.40, with an EV/FCF ratio of 1.33.

EV / Earnings	6.77
EV / Sales	0.04
EV / EBITDA	2.40
EV / EBIT	4.59
EV / FCF	1.33

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.03.

Current Ratio	1.08
Quick Ratio	0.92
Debt / Equity	0.03
Debt / EBITDA	0.17
Debt / FCF	0.10
Interest Coverage	34.59

Financial Efficiency

Return on equity (ROE) is 5.49% and return on invested capital (ROIC) is 5.31%.

Return on Equity (ROE)	5.49%
Return on Assets (ROA)	1.10%
Return on Capital (ROIC)	5.31%
Revenue Per Employee	2.89M
Profits Per Employee	15,195
Employee Count	230
Asset Turnover	2.12
Inventory Turnover	14.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.03% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+13.03%
50-Day Moving Average	0.78
200-Day Moving Average	0.72
Relative Strength Index (RSI)	41.79
Average Volume (20 Days)	55,126

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Farmaceutica REMEDIA had revenue of RON 664.14 million and earned 3.49 million in profits. Earnings per share was 0.03.

Revenue	664.14M
Gross Profit	34.19M
Operating Income	5.51M
Pretax Income	7.81M
Net Income	3.49M
EBITDA	10.05M
EBIT	5.51M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 47.08 million in cash and 1.69 million in debt, giving a net cash position of 45.39 million or 0.49 per share.

Cash & Cash Equivalents	47.08M
Total Debt	1.69M
Net Cash	45.39M
Net Cash Per Share	0.49
Equity (Book Value)	64.29M
Book Value Per Share	0.52
Working Capital	23.53M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 19.37 million and capital expenditures -1.63 million, giving a free cash flow of 17.74 million.

Operating Cash Flow	19.37M
Capital Expenditures	-1.63M
Free Cash Flow	17.74M
FCF Per Share	0.19

Full Cash Flow Statement

Margins

Gross margin is 5.15%, with operating and profit margins of 0.83% and 0.53%.

Gross Margin	5.15%
Operating Margin	0.83%
Pretax Margin	1.18%
Profit Margin	0.53%
EBITDA Margin	1.51%
EBIT Margin	0.83%
FCF Margin	2.67%

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 6.81%.

Dividend Per Share	0.05
Dividend Yield	6.81%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	119.88%
Buyback Yield	-7.37%
Shareholder Yield	-0.56%
Earnings Yield	4.56%
FCF Yield	25.68%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Farmaceutica REMEDIA has an Altman Z-Score of 2.25. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.25
Piotroski F-Score	n/a